We wish to thank the following organizations that are participating as exhibitors.


The materials they provide are independent of the CME program and not part of the CME educational materials. These entities did not influence or determine the content of AAP Colorado’s 2024 Annual Conference. Participation in the exhibits is optional and encouraged.


To learn more about these exhibitors, please see their information below.

Action Behavior Centers – ABA Therapy for Autism (ABC) began with a vision to provide better mental health services to children on the Autism Spectrum. It has continued to evolve with the changing landscape of ABA to stay at the forefront of the field. ABC is dedicated to creating a safe and nurturing environment where your patient can learn, grow, and develop important life skills to reach their full potential. Our team of highly trained professionals will work closely with your patient and their family, helping them develop critical skills, improve communication, and build meaningful connections. At ABC, we are committed to increasing access to care through our “No Waitlist” policy for both ABA therapy and Autism diagnostic services. We look forward to connecting with you to share how we can support your patients and our local pediatric community through the highest quality of compassionate care, accessibility, and convenience for you, your patients, and their families. Contact: Andrea Delgado, (956) 624-4825, andrea.delgado@actionbehavior.com.

Behavioral Innovations – Life Changing Autism Care for Children.  When it comes to finding autism treatment for your child, we understand you have options. That’s why we do our best to ensure each family that walks through our doors experiences what sets us apart. Safe, reliable, and compassionate care you can count on from the moment you first contact us.  Our promise to you is to be your trusted partner in this journey. Whether you are looking for autism testing or personalized Applied Behavior Analysis (ABA) therapy, we make it easy for you to get the help you and your child need. We are the only ABA provider to implement over two decades of successful outcomes into our thoughtful and proven treatment plans. Connect with our compassionate team to learn more: www.behavioral-innovations.com, 720-571-4796  Read family testimonials here!

For information contact Jennie Wurst, MS, RD at jwurst@bmrn.com, or visit https://www.biomarin.com/.

At CeraVe, we work with dermatologists to develop our products and have done this since the brand was founded in 2005. Our formulations, ingredients, and even product ideas are developed with dermatologists. Developed with dermatologists is more than a line in our logo – it’s at the very core of who we are and a key part of our brand DNA.

At Chiesi, we are making a rare difference. We strive to create a world where it is common to have a therapy for all diseases and we act as a force for good, for society and the planet. As a family business, we deliver innovative therapies and solutions for people affected by rare diseases. Our goal is to ensure equal access so as many people as possible can experience their most fulfilling life.

The Colorado Immunization Branch, at the Colorado Department of Public Health and Environment, works to reduce vaccine-preventable disease by developing and implementing programs designed to positively influence the uptake of immunizations across the lifespan. The Immunization Branch utilizes a variety of strategies to promote education, optimize vaccine resources, assure access to vaccines and maintain the Colorado Immunization Information System (CIIS), a confidential, population-based, computerized information system that collects and consolidates immunization data for Coloradans of all ages from a variety of sources and provides tools for designing and sustaining effective immunization strategies at the provider and program levels. The Immunization Branch also operates the Federal Vaccines for Children (VFC) program, the Federal Section 317 program, and all immunization education and outreach activities. Learn more by visiting the organization’s website here.

Colorado Pediatric Psychiatry Consultation & Access Program (CoPPCAP) provides consultation at no cost to pediatric care providers by licensed child & adolescent psychiatrists, psychologists, and specialized community resource navigators. Learn more by watching their informative video here and visiting the organization’s website here. Contact: Kristin Larpenter, Info@coppcap.org, 1-888-910-0153.

Colorado Pediatric Psychiatry Consultation & Access Program (CoPPCAP) provides consultation at no cost to pediatric care providers by licensed child & adolescent psychiatrists, psychologists, and specialized community resource navigators. Learn more by watching their informative video here and visiting the organization’s website here. Contact: Kristin Larpenter, Info@coppcap.org, 1-888-910-0153.

The Consortium for Outcome Measures and Biomarkers for Neurodevelopmental Disorders (COMBINEDBrain) is a non-profit organization devoted to speeding the path to clinical treatments for people with rare genetic neurological disorders by pooling efforts, studies, and data. COMBINEDBrain is currently conducting Project FIND-OUT and is interested in partnering with pediatricians on this project. 

Underdiagnosis and late diagnosis are significant problems in rare genetic neurodevelopmental disorders where early treatment yields the best outcomes. Fewer than a quarter of patients with a rare genetic neurodevelopmental disorder currently have a confirmed genetic diagnosis and the average time to diagnosis from the development of symptoms is more than 30 months. The goal of Project FIND-OUT is to increase the diagnosis rate and reduce the time to diagnosis in infants with rare genetic neurodevelopmental disorders. We are currently conducting our pilot study where we are providing free whole genome sequencing and genetic counseling to 50 infants between the ages of 3 – 12 months who have two or more symptoms of neurodevelopmental disorders. For more information, see projectfindout.org.

CSL Seqirus is part of CSL. As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. With state-of-the-art production facilities in the U.S., the U.K. and Australia, and leading R & D capabilities, CSL Seqirus utilizes cell, adjuvant and egg technologies to offer a broad portfolio of differentiated influenza vaccines in more than 20 countries around the world.

Founded more than 40 years ago, Dairy MAX is one of the leading regional dairy councils in America – representing more than 900 dairy farmers and serving communities in eight states: Colorado, southwest Kansas, Louisiana, Montana, New Mexico, western Oklahoma, Texas and Wyoming. A nonprofit organization, Dairy MAX is part of a nationwide effort to promote American agriculture, support dairy farming and drive impact for every dairy farmer. The organization operates five audience outreach programs: business development, consumer marketing, health and wellness, industry image and relations and school marketing. For more information about Dairy MAX and its team of experts, visit DairyMAX.org. Dairy resources and delicious recipes are available at DairyDiscoveryZone.com.

GSK unites science, technology and talent to get ahead of disease together. We prevent and treat disease with vaccines, specialty and general medicines.

Healthy Young Minds (HYM) is Redefining the Traditional Therapy Model Online. We founded Healthy Young Minds with the belief that every child should have what we want for our own kids: Access to exceptional, effective mental and behavioral health care online that helps every young mind achieve its greatest potential.  Based in Colorado, HYM accepts Medicaid, private pay, Kaiser of Colorado and Cigna/Evernorth.  HYM provides the following services: Counseling, Testing and Evaluation, Speech and Language Therapy, Occupational Therapy, Art Therapy, Behavioral Therapy, Music Therapy and Forensic Evaluations and has licensed providers who can begin to treat kids from across our state immediately.  View our flyer in English and Spanish. Learn more by visiting HYM’s website here, or call or email Julie Norman, HYM’s lead therapist at 303-317-6504 or julie@healthyyoungminds.com.

Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (DMD) and limb-girdle muscular dystrophies (LGMDs), and we currently have more than 40 programs in various stages of development. Our vast pipeline is driven by our multi-platform Precision Genetic Medicine Engine in gene therapy, RNA and gene editing. For more information contact Lori Amels at LAmels@sarepta.com, 559-287-2221, or visit www.sarepta.com.

Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company; our passion and pursuit of potentially life-changing treatments are rooted in our history. We know patients with rare diseases have spent their lives overcoming challenges. That’s why for 70+ years we’ve been working to support them in their fight. To learn more visit www.takeda.com or contact Jennifer.oberly@takeda.com or phone at (303) 802-0472.